Climate Change Data

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Developed deep relationships with key opinion leaders, investigators and sites; maintains a range of specialty population databases to ensure that targeted patient populations can be evaluated against study inclusion/exclusion criteria; fosters collaborative relationships between sites, physicians, patient advocacy groups, academic thought leaders and sponsors to support clinical development strategies that are tailored to specific rare diseases and focused on the needs of these special patients to facilitate their participation in clinical trials.

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Scarcity of rare disease patients, difficulties in biological and targeted therapy development, similar project competition, trial design complexity/technicality and novel mechanisms of action.

Mitigation Strategies

• Specialization in nonmalignant hematology to anticipate and proactively solve for important issues; use of Trusted Process®, a proven, metrics-driven system that standardizes clinical development for predictable study execution and operational excellence.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed